Diagnostic startup ChipCare targets $18.8 mln Series B
Toronto-based diagnostic startup ChipCare is seeking to raise $18.8 million in Series B funding. Biotech Alliances International is leading the round.
17 November 2016•1 min read
Toronto-based diagnostic startup ChipCare is seeking to raise $18.8 million in Series B funding. Biotech Alliances International is leading the round.
